ST星源(000005.SZ):2021年度預盈1.2億元-1.7億元 同比扭虧
格隆匯1月26日丨ST星源(000005.SZ)公佈2021年度業績預吿,公司預計實現2021年度歸屬於上市公司股東的淨利潤為1.2億元-1.7億元,同比扭虧為盈;預計實現2021年度扣除非經常性損益後的淨虧損為1.04億元-1.54億元。
業績變動原因系:
1、2020年度非經常性損益:南油項目優先股收益約6000萬元;“肇慶項目”計提資產減值約418459959.62元;計提商譽減值約167508100.00元。
2、2021年度非經常性損益:南油項目優先股收益約8000萬元;南油項目“拆遷補償階段”補償款19356萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.